Protalix price target raised to $15 from $10 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Protalix (PLX) to $15 from $10 and keeps a Buy rating on the shares. The firm says the Elfabrio commercial trajectory continues to accelerate.